TP53 and cancer: C-MYC plays a pivotal role in cancer taking part in multiple processes, such as metabolism, cell cycle and apoptosis, and its deregulation along with the loss of p53 is associated with the maintenance of the cancer stem cells (CSC) pool as well as the promotion of genomic instability and the inhibition of apoptosis even after severe damage (62, 63).